Innovation

Shown here is the research team that discovered monoclonal antibodies that protect against COVID-19 in high-risk individuals.
August 24, 2022

COVID antibody research conducted at VUMC lands national award

A long-acting antibody combination discovered at Vanderbilt University Medical Center that protects against COVID-19 in high-risk individuals has received a gold medal in the 2022 R&D 100 awards program announced Aug. 22 by R&D World Magazine.

By Bill Snyder
August 8, 2022

Say hello. ‘DNA’ podcast series coming Fall 2022

Be one of the first to preview the all-new ‘Vanderbilt Health DNA: Discoveries in Action’ podcast series. #ListenDNA.

By Holly Fletcher
July 15, 2022

‘DNA’ podcast goes live: July 20 Twitter Spaces chat about mental health, teens

Season 3 of the “Vanderbilt Health DNA: Discoveries in Action” podcast series will kick off with a live Twitter Spaces chat about mental health, featuring several teens from the Boys & Girls Clubs of Middle Tennessee.

By Holly Fletcher
From left, Jeff Balser, MD, PhD, Orrin Ingram, Jennifer Pietenpol, PhD, Mary Brock, John Brock III, John Brock IV, Major Brock, Morgan Brock, Adam Dixon, Rebecca Brock Dixon.
May 31, 2022

$10 million gift from Brock family to establish Brock Family Center for Applied Innovation

By Nancy Humphrey
May 19, 2022

Steaban receives Outstanding Operational Partner Award

Steaban, MSN, RN, NEA-BC, received the Outstanding Operational Partner Award during the Vanderbilt Symposium on Implementation Research in the Learning Health System.

By VUMC News and Communications
VUMC’s new automated biobanking system can store as many as 10 million biospecimens.
April 6, 2022

Major grant renewal to provide five more years of support for VICTR

Vanderbilt University Medical Center has competed successfully for a third renewal of its Clinical and Translational Science Award by the National Institutes of Health.

By Bill Snyder
February 17, 2022

Pandemic leads to broader use of monoclonal antibodies

Antiviral drugs and coronavirus-fighting monoclonal antibodies, including those discovered at Vanderbilt University Medical Center, remain crucially important in the continuing fight against COVID-19.
By Bill Snyder
December 9, 2021

Antibodies discovered at Vanderbilt for prevention of COVID-19 granted FDA emergency use authorization

The U.S. Food and Drug Administration granted emergency use authorization (EUA) to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination which  protects against COVID-19, discovered last year at Vanderbilt University Medical Center.
By Bill Snyder
December 2, 2021

Long-acting antibody combo developed at VUMC reduces COVID-19 risk and symptoms

By Bill Snyder
November 11, 2021

VUMC team puts tool to reduce heart failure admissions to test

Vanderbilt researchers have developed a risk stratification tool to predict outcomes and avoid unnecessary hospital admissions after emergency department visits for acute heart failure.
By Bill Snyder
May 18, 2021

Rosenbloom appointed to National Library of Medicine’s Biomedical Informatics, Library and Data Sciences Review Committee

Trent Rosenbloom, MD, MPH, professor and vice chair of Faculty Affairs in the Department of Biomedical Informatics, has been appointed to the National Library of Medicine’s (NLM) Biomedical Informatics, Library and Data Sciences (BILDS) Review Committee.
By Mia Garchitorena-Scancarelli
September 24, 2020

REDCap helps state of Washington scale up its testing capacity

Until it was eclipsed by New York in mid-April, the state of Washington had the highest absolute number of COVID-19 cases in the United States.
By Bill Snyder
September 24, 2020

Follow-up calls don’t impact readmission, mortality rates: study

Following up with adult general medicine patients by phone within the week after their hospital discharge as a stand-alone intervention has no impact on readmissions, mortality or patient satisfaction, according to a new study by Vanderbilt University Medical Center researchers.
By Kelsey Herbers